Drug Type Small molecule drug |
Synonyms- |
Mechanism p300-CBP transcription factors inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC27H26N6O |
InChIKeySEDFZSHSBUXKAC-NIYFSFCBSA-N |
CAS Registry2374971-81-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 23 Apr 2020 | |
Neoplasms | Preclinical | IN | 23 Apr 2020 |